{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:12:22Z","timestamp":1788577942309,"version":"build-2803163510"},"reference-count":316,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009845","name":"Ovarian Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003354","name":"Garnett Passe and Rodney Williams Memorial Foundation","doi-asserted-by":"publisher","award":["2019485"],"award-info":[{"award-number":["2019485"]}],"id":[{"id":"10.13039\/501100003354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","award":["2023\/IIRS0063"],"award-info":[{"award-number":["2023\/IIRS0063"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["#IG250200299"],"award-info":[{"award-number":["#IG250200299"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004176","name":"Miltenyi Biotec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020492","name":"Translational Research Institute Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009844","name":"PA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011302","name":"Children's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018675","name":"Kids' Cancer Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.semcancer.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:58:54Z","timestamp":1781308734000},"page":"1-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hidden architecture of resistance: The extracellular matrix in melanoma\u2019s immune landscape"],"prefix":"10.1016","volume":"125","author":[{"given":"Yimeng","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisella","family":"Edny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janin","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Souza-Fonseca-Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-5360","authenticated-orcid":false,"given":"Nikolas K.","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10400","key":"10.1016\/j.semcancer.2026.06.004_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1751-1097.1989.tb04123.x","article-title":"ULTRAVIOLET RADIATION - INDUCED MALIGNANT MELANOMA IN Monodelphis domestica","volume":"50","author":"D. Ley","year":"1989","journal-title":"Photochem. Photobiol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archderm.141.4.477","article-title":"Association of UV Index, Latitude, and Melanoma Incidence in Nonwhite Populations\u2014US Surveillance, Epidemiology, and End Results (SEER) Program, 1992\u20132001","volume":"141","author":"Eide","year":"2005","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-025-00603-8","article-title":"Cutaneous melanoma","volume":"11","author":"Tasdogan","year":"2025","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2022.24888","article-title":"What Is Melanoma?","volume":"329","author":"Wang","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2026.06.004_bib6","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment \u2013 Update 2024","volume":"215","author":"Garbe","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib7","series-title":"Seminars in cancer biology","article-title":"editors. Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy","author":"Queirolo","year":"2019"},{"issue":"30","key":"10.1016\/j.semcancer.2026.06.004_bib8","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic Therapy for Melanoma: ASCO Guideline Update","volume":"41","author":"Seth","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.semcancer.2026.06.004_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"New. Engl. J. Med."},{"issue":"43","key":"10.1016\/j.semcancer.2026.06.004_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_390614","article-title":"Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift","author":"Hieken","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"issue":"13","key":"10.1016\/j.semcancer.2026.06.004_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17132265","article-title":"Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review","volume":"17","author":"Muto","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.semcancer.2026.06.004_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa2402604","article-title":"Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma","volume":"391","author":"Blank","year":"2024","journal-title":"New. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"New. Engl. J. Med."},{"issue":"16_","key":"10.1016\/j.semcancer.2026.06.004_bib14","article-title":"Systemic therapies for advanced melanoma after immunotherapy failure: Efficacy and safety insights","volume":"43","author":"Ramanarayanan","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002820","article-title":"Search for effective treatments in patients with advanced refractory melanoma continues: can novel intratumoral therapies deliver?","volume":"9","author":"Najjar","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fimmu.2023.1270981","article-title":"The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature","volume":"14","author":"Fejza","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-025-02294-x","article-title":"Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors","volume":"24","author":"Wawrzyniak","year":"2025","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s43018-024-00794-1","article-title":"Determinants of resistance and response to melanoma therapy","volume":"5","author":"Robertson","year":"2024","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2026.06.004_bib21","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fonc.2022.811586","article-title":"Tertiary Lymphoid Structures and Chemokine Landscape in Virus-Positive and Virus-Negative Merkel Cell Carcinoma","volume":"12","author":"Nakamura","year":"2022","journal-title":"Front. Oncol."},{"issue":"7791","key":"10.1016\/j.semcancer.2026.06.004_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.06.004_bib23","series-title":"Stem Cell Biology and Tissue Engineering in Dental Sciences","first-page":"25","article-title":"Chapter 3 - Extracellular Matrix (ECM) Molecules","author":"Kaur","year":"2015"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","article-title":"Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility","volume":"9","author":"Kaur","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib25","doi-asserted-by":"crossref","DOI":"10.1117\/1.BIOS1.1.015004","article-title":"Quantifying in vivo collagen reorganization during immunotherapy in murine melanoma with second harmonic generation imaging","volume":"1","author":"Heaton","year":"2024","journal-title":"Biophotonics Discov."},{"key":"10.1016\/j.semcancer.2026.06.004_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/bs.acr.2022.06.001","article-title":"The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma","volume":"157","author":"Mohammed","year":"2023","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s43587-024-00581-8","article-title":"Age-dependent loss of HAPLN1 erodes vascular integrity via indirect upregulation of endothelial ICAM1 in melanoma","volume":"4","author":"Marino-Bravante","year":"2024","journal-title":"Nat. Aging"},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4+ T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/pcmr.12926","article-title":"The tumour immune landscape and its implications in cutaneous melanoma","volume":"34","author":"Attrill","year":"2021","journal-title":"Pigment. Cell. & Melanoma Res."},{"key":"10.1016\/j.semcancer.2026.06.004_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","article-title":"Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment","volume":"59","author":"Marzagalli","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"15","key":"10.1016\/j.semcancer.2026.06.004_bib31","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.3390\/ijms25158523","article-title":"Innate Immune Cells in Melanoma: Implications for Immunotherapy","volume":"25","author":"Trocchia","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.06.004_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.05.038","article-title":"Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic insights","author":"Coleborn","year":"2025","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","article-title":"The emerging roles of \u03b3\u03b4 T cells in cancer immunotherapy","volume":"20","author":"Mensurado","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fimmu.2020.00073","article-title":"Tumor microenvironment-associated extracellular matrix components regulate NK cell function","volume":"11","author":"Rossi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6055","article-title":"Chemokines as possible therapeutic targets in metastatic melanoma","author":"Basson","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer gene Ther."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.semcancer.2026.06.004_bib38","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.3390\/ijms25126532","article-title":"Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets","volume":"25","author":"Reschke","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.06.004_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102338","article-title":"the right place at the right time: tissue-resident memory T cells in immunity to cancer","volume":"83","author":"Ramirez","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell. Death & Differ."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43556-021-00038-z","article-title":"Targeting regulatory T cells for immunotherapy in melanoma","volume":"2","author":"Huang","year":"2021","journal-title":"Mol. Biomed."},{"issue":"13","key":"10.1016\/j.semcancer.2026.06.004_bib42","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170762","article-title":"Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target","volume":"133","author":"Ozbay Kurt","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"21","key":"10.1016\/j.semcancer.2026.06.004_bib43","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.3390\/ijms21218359","article-title":"The influence of tumor microenvironment on immune escape of melanoma","volume":"21","author":"Simiczyjew","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2026.06.004_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102499","article-title":"Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?","volume":"113","author":"Ziogas","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.semcancer.2026.06.004_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102409","article-title":"Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment","volume":"86","author":"Alim","year":"2024","journal-title":"Curr. Opin. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.molmed.2021.07.009","article-title":"Extracellular matrix-based cancer targeting","volume":"27","author":"Karamanos","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.semcancer.2026.06.004_bib47","article-title":"Phenotypic melanoma heterogeneity is regulated through cell-matrix interaction-dependent changes in tumor microarchitecture","author":"Spoerri","year":"2020","journal-title":"BioRxiv"},{"issue":"13","key":"10.1016\/j.semcancer.2026.06.004_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137165","article-title":"A Transcriptome-Wide Isoform Landscape of Melanocytic Nevi and Primary Melanomas Identifies Gene Isoforms Associated with Malignancy","volume":"22","author":"Hakobyan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","article-title":"A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth","volume":"141","author":"Roesch","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.06.004_bib50","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3389\/fonc.2018.00173","article-title":"Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance","volume":"8","author":"Ahmed","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.874429","article-title":"Identification of Transcriptional Heterogeneity and Construction of a Prognostic Model for Melanoma Based on Single-Cell and Bulk Transcriptome Analysis","volume":"10","author":"Kang","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021601","article-title":"Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance","volume":"24","author":"Hossain","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2009","key":"10.1016\/j.semcancer.2026.06.004_bib53","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","article-title":"Collagen Structure and Stability","volume":"78","author":"Shoulders","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.semcancer.2026.06.004_bib54","first-page":"173","article-title":"Collagen in human tissues: structure, function, and biomedical implications from a tissue engineering perspective","author":"Balasubramanian","year":"2013","journal-title":"Polym. Compos. Polyolefin FractionationPolym. Pept. Collagens"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/jocd.12450","article-title":"Collagen: A review on its sources and potential cosmetic applications","volume":"17","author":"Avila Rodr\u00edguez","year":"2018","journal-title":"J. Cosmet. Dermatol."},{"issue":"16","key":"10.1016\/j.semcancer.2026.06.004_bib56","article-title":"Current Insights into Collagen Type I","volume":"13","author":"Naomi","year":"2021","journal-title":"Polym. (Basel)"},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092126","article-title":"Molecular Mechanisms of Dermal Aging and Antiaging Approaches","volume":"20","author":"Shin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.semcancer.2026.06.004_bib58","first-page":"2524","article-title":"The content and ratio of type I and III collagen in skin differ with age and injury","volume":"10","author":"Cheng","year":"2011","journal-title":"Afr. J. Biotechnol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib59","article-title":"Skin collagen through the lifestages: Importance for skin health and beauty","volume":"8","author":"Reilly","year":"2021","journal-title":"Plast. Aesthetic Res."},{"issue":"12","key":"10.1016\/j.semcancer.2026.06.004_bib60","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","article-title":"Collagens\u2014structure, function, and biosynthesis","volume":"55","author":"Gelse","year":"2003","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm1063","article-title":"Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa","volume":"10","author":"Woodley","year":"2004","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib62","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1083\/jcb.103.4.1577","article-title":"Type VII collagen is a major structural component of anchoring fibrils","volume":"103","author":"Sakai","year":"1986","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib63","series-title":"Biochemistry of collagens, laminins and elastin: structure, function and biomarkers","author":"Karsdal","year":"2023"},{"issue":"23","key":"10.1016\/j.semcancer.2026.06.004_bib64","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41388-018-0209-0","article-title":"Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing","volume":"37","author":"Miskolczi","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib65","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014647","article-title":"The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices*","volume":"11","author":"Naba","year":"2012","journal-title":"Mol. & Cell. Proteom."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib66","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/ijc.23147","article-title":"Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma","volume":"122","author":"van Kempen","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cdp.2004.09.003","article-title":"Control of melanoma cell invasion by type IV collagen","volume":"29","author":"Pasco","year":"2005","journal-title":"Cancer Detect. Prev."},{"issue":"17","key":"10.1016\/j.semcancer.2026.06.004_bib68","first-page":"4796","article-title":"Type IV collagen-mediated melanoma cell adhesion and migration: involvement of multiple, distinct domains of the collagen molecule","volume":"49","author":"Chelberg","year":"1989","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.semcancer.2026.06.004_bib69","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1073\/pnas.170290997","article-title":"Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1","volume":"97","author":"Henriet","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib70","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1038\/srep08879","article-title":"vivo Quantification of the Structural Changes of Collagens in a Melanoma Microenvironment with Second and Third Harmonic Generation Microscopy","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.06.004_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.864302","article-title":"The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance","volume":"9","author":"Fromme","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.semcancer.2026.06.004_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-016-0004","article-title":"Solid stress and elastic energy as measures of tumour mechanopathology","volume":"1","author":"Nia","year":"2016","journal-title":"Nat. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib73","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41389-023-00452-8","article-title":"The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance","volume":"12","author":"Diazzi","year":"2023","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib75","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark Jr","year":"1969","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40425-018-0474-z","article-title":"Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients","volume":"6","author":"Jensen","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001193","article-title":"Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma","volume":"8","author":"Hurkmans","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1034\/j.1600-0560.2000.027002067.x","article-title":"Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy","volume":"27","author":"Schaumburg-Lever","year":"2000","journal-title":"J. Cutan. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib79","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2006.051321","article-title":"The role of type IV collagen and basement membranes in cancer progression and metastasis","volume":"168","author":"Tanjore","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib80","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/cancers12102786","article-title":"Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade","volume":"12","author":"Jensen","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.06.004_bib81","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.matbio.2017.12.005","article-title":"Granzyme B in skin inflammation and disease","volume":"75-76","author":"Turner","year":"2019","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib82","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.immuni.2014.11.012","article-title":"Granzyme B Promotes Cytotoxic Lymphocyte Transmigration via Basement Membrane Remodeling","volume":"41","author":"Prakash","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13086","article-title":"Dual roles of granzyme B","volume":"94","author":"Wang","year":"2021","journal-title":"Scand. J. Immunol."},{"issue":"6633","key":"10.1016\/j.semcancer.2026.06.004_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/science.abp8964","article-title":"The extracellular matrix and the immune system: A mutually dependent relationship","volume":"379","author":"Sutherland","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2026.06.004_bib85","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.matbio.2019.02.003","article-title":"Collagen fiber structure guides 3D motility of cytotoxic T lymphocytes","volume":"85-86","author":"Pruitt","year":"2020","journal-title":"Matrix Biol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib86","first-page":"153","article-title":"Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma","author":"Sha","year":"2023","journal-title":"Pharm. Pers. Med."},{"key":"10.1016\/j.semcancer.2026.06.004_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155267","article-title":"B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma","volume":"256","author":"Shen","year":"2024","journal-title":"Pathol. - Res. Pract."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib88","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/jid.2013.114","article-title":"B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma","volume":"133","author":"Wang","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","article-title":"Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy","volume":"15","author":"Zhao","year":"2022","journal-title":"J. Hematol. & Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib90","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cells10051020","article-title":"Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment","volume":"10","author":"Grote","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.semcancer.2026.06.004_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0556-6","article-title":"Collagen density regulates the activity of tumor-infiltrating T cells","volume":"7","author":"Kuczek","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib92","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4049\/jimmunol.1900789","article-title":"Collagen Density Modulates the Immunosuppressive Functions of Macrophages","volume":"205","author":"Larsen","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102343","article-title":"Tumor-stroma proportion is associated with increased M2 macrophage abundance and predicts the resistance to immune checkpoint blockade in breast cancer","volume":"54","author":"Liu","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biomaterials.2017.02.004","article-title":"Decellularized human colorectal cancer matrices polarize macrophages towards an anti-inflammatory phenotype promoting cancer cell invasion via CCL18","volume":"124","author":"Pinto","year":"2017","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib95","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/bjd.12430","article-title":"A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy","volume":"169","author":"Tong","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib96","article-title":"A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers","volume":"7","author":"Hanley","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib97","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1038\/s41598-020-63368-y","article-title":"Altered organization of collagen fibers in the uninvolved human colon mucosa 10\u2009cm and 20\u2009cm away from the malignant tumor","volume":"10","author":"Despotovi\u0107","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79854-6","article-title":"Comparative evaluation of collagen modifications in breast cancer in human and canine carcinomas","volume":"14","author":"Vargas Garcia","year":"2024","journal-title":"Sci. Rep."},{"issue":"7886","key":"10.1016\/j.semcancer.2026.06.004_bib99","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion","volume":"599","author":"Sun","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.06.004_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122900","article-title":"Matrix stiffening from collagen fibril density and alignment modulates YAP-mediated T-cell immune suppression","volume":"315","author":"Sapudom","year":"2025","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib101","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.hlife.2024.01.003","article-title":"Discoidin domain receptor 1 as a potent therapeutic target in solid tumors","volume":"2","author":"Bibi","year":"2024","journal-title":"hLife"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib102","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1038\/s41598-023-27975-9","article-title":"A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance","volume":"13","author":"Yang","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib103","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/pcmr.12809","article-title":"Discoidin domain receptors: A promising target in melanoma","volume":"32","author":"Reger de Moura","year":"2019","journal-title":"Pigment. Cell. & Melanoma Res."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib104","first-page":"378","article-title":"Discoidin domain receptors: Microenvironment sensors that promote cellular migration and invasion","volume":"12","author":"Itoh","year":"2018","journal-title":"Cell. Adhes. & Migr."},{"key":"10.1016\/j.semcancer.2026.06.004_bib105","first-page":"1","article-title":"Discoidin Domain Receptor 1 as Modifier of Collagen in Tumor Extracellular Matrix: Recent Advances and Therapeutic Possibilities","volume":"8","author":"Dan","year":"2022","journal-title":"Curr. Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib106","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006720","article-title":"A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer","volume":"11","author":"Liu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcskn.2024.100121","article-title":"Discoidin domain receptor 1, a melanoma immunomodulator","volume":"2","author":"Lutz","year":"2024","journal-title":"EJC Skin. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000591","article-title":"Yap suppresses T-cell function and infiltration in the tumor microenvironment","volume":"18","author":"Stampouloglou","year":"2020","journal-title":"PLoS. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib109","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1038\/s41467-020-18298-8","article-title":"Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41577-025-01181-2","article-title":"Inhibitory pattern recognition receptors: lessons from LAIR1","volume":"25","author":"Pascoal Ramos","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib111","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1189\/jlb.0907609","article-title":"The inhibitory collagen receptor LAIR-1 (CD305)","volume":"83","author":"Meyaard","year":"2008","journal-title":"J. Leucoc. Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib112","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.20052554","article-title":"Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1","volume":"203","author":"Lebbink","year":"2006","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib113","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1074\/jbc.RA119.011150","article-title":"Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway","volume":"295","author":"Park","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2026.06.004_bib114","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fimmu.2021.733561","article-title":"Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1","volume":"12","author":"Vijver","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib115","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/intimm\/dxm071","article-title":"Mouse leukocyte-associated Ig-like receptor-1 (mLAIR-1) functions as an inhibitory collagen-binding receptor on immune cells","volume":"19","author":"Lebbink","year":"2007","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib116","doi-asserted-by":"crossref","first-page":"a002279","DOI":"10.1101\/cshperspect.a002279","article-title":"ZAP-70: an essential kinase in T-cell signaling","volume":"2","author":"Wang","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib117","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1740477","article-title":"Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1","volume":"9","author":"Xu","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.semcancer.2026.06.004_bib118","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62927","article-title":"Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction","volume":"10","author":"Ramos","year":"2021","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abk3327","article-title":"Extracellular matrix proteins regulate NK cell function in peripheral tissues","volume":"8","author":"Bunting","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib121","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1074-7613(00)80530-0","article-title":"LAIR-1, a Novel Inhibitory Receptor Expressed on Human Mononuclear Leukocytes","volume":"7","author":"Meyaard","year":"1997","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib122","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40164-025-00691-y","article-title":"Targeting collagen to optimize cancer immunotherapy","volume":"14","author":"Wang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib123","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1608132","article-title":"The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma","volume":"8","author":"Chen","year":"2019","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib124","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00418-012-0981-9","article-title":"Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis","volume":"138","author":"Krenacs","year":"2012","journal-title":"Histochem. Cell. Biol."},{"issue":"50","key":"10.1016\/j.semcancer.2026.06.004_bib125","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1038\/s41388-019-0961-9","article-title":"The dysfunction of BP180\/collagen XVII in keratinocytes promotes melanoma progression","volume":"38","author":"Hwang","year":"2019","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib126","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib127","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-med-051013-052304","article-title":"Regulation of tumor metastasis by myeloid-derived suppressor cells","volume":"66","author":"Condamine","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib128","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1111\/cas.15952","article-title":"Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment","volume":"114","author":"Kashiwagi","year":"2023","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib129","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","article-title":"LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis","volume":"73","author":"Cox","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib130","first-page":"1926","article-title":"A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer","volume":"31","author":"Cetin","year":"2024","journal-title":"Chem. & Biol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib131","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70536","article-title":"Systematic Characterisation and Analysis of Lysyl Oxidase Family Members as Drivers of Tumour Progression and Multiple Drug Resistance","volume":"29","author":"Liu","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib132","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41467-022-33148-5","article-title":"Topical application of an irreversible small molecule inhibitor of lysyl oxidases ameliorates skin scarring and fibrosis","volume":"13","author":"Chaudhari","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.06.004_bib133","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58688","article-title":"Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment","volume":"10","author":"Nicolas-Boluda","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib134","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib135","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib136","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0169-409X(91)90004-V","article-title":"Turnover of hyaluronan in the tissues","volume":"7","author":"Laurent","year":"1991","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib137","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/derm.21923","article-title":"Hyaluronic acid: A key molecule in skin aging","volume":"4","author":"Papakonstantinou","year":"2012","journal-title":"Derm. -Endocrinol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73177-y","article-title":"Hyaluronan regulates synapse formation and function in developing neural networks","volume":"10","author":"Wilson","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111525","article-title":"Hyaluronan: Metabolism and Function","volume":"10","author":"Kobayashi","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/gels11040281","article-title":"Hyaluronic Acid and Skin: Its Role in Aging and Wound-Healing Processes","volume":"11","author":"Chyli\u0144ska","year":"2025","journal-title":"Gels"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2407-13-181","article-title":"Inverse expression of hyaluronidase 2 and hyaluronan synthases 1\u20133 is associated with reduced hyaluronan content in malignant cutaneous melanoma","volume":"13","author":"Hanna","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib142","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12885-016-2344-8","article-title":"Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma","volume":"16","author":"Poukka","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.971278","article-title":"Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression","volume":"13","author":"Donelan","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib144","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1073\/pnas.1117560109","article-title":"Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis","volume":"109","author":"Hirose","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0625.2007.00638.x","article-title":"Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4","volume":"17","author":"Voelcker","year":"2008","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib146","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/cells11010120","article-title":"Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy\u2014An Integrated View into Other Neoplasms and Chemokine Networks","volume":"11","author":"Filimon","year":"2022","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.semcancer.2026.06.004_bib147","doi-asserted-by":"crossref","first-page":"13558","DOI":"10.3390\/ijms252413558","article-title":"Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma","volume":"25","author":"Szczygielski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib148","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1232235","article-title":"Low-molecular-weight hyaluronan (LMW-HA) accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion","volume":"5","author":"Du","year":"2016","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib149","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-18-0168","article-title":"Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis","volume":"9","author":"Ecker","year":"2019","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib150","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ajpath.2019.12.006","article-title":"Intercellular Adhesion Molecule 1 Functions as an Efferocytosis Receptor in Inflammatory Macrophages","volume":"190","author":"Wiesolek","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"59","key":"10.1016\/j.semcancer.2026.06.004_bib151","doi-asserted-by":"crossref","first-page":"99580","DOI":"10.18632\/oncotarget.20884","article-title":"Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma","volume":"8","author":"Galore-Haskel","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2026.06.004_bib152","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/1471-2407-12-455","article-title":"LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro","volume":"12","author":"Ghislin","year":"2012","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib153","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tem.2022.02.002","article-title":"The membrane receptor CD44: novel insights into metabolism","volume":"33","author":"Weng","year":"2022","journal-title":"Trends Endocrinol. & Metab."},{"key":"10.1016\/j.semcancer.2026.06.004_bib154","article-title":"The Cancer Stem Cell Marker CD44 Play Key Roles in Immune Suppression\/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis in Several","author":"Dzobo","year":"2021","journal-title":"Human. Cancers"},{"issue":"24","key":"10.1016\/j.semcancer.2026.06.004_bib155","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1111\/febs.16179","article-title":"The state of CD44 activation in cancer progression and therapeutic targeting","volume":"289","author":"Guo","year":"2022","journal-title":"FEBS J."},{"issue":"33","key":"10.1016\/j.semcancer.2026.06.004_bib156","doi-asserted-by":"crossref","first-page":"22513","DOI":"10.1074\/jbc.M708319200","article-title":"CD44-Epidermal Growth Factor Receptor Interaction Mediates Hyaluronic Acid-promoted Cell Motility by Activating Protein Kinase C Signaling Involving Akt, Rac1, Phox, Reactive Oxygen Species, Focal Adhesion Kinase, and MMP-2*","volume":"283","author":"Kim","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.semcancer.2026.06.004_bib157","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/sj.onc.1204435","article-title":"Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid","volume":"20","author":"Ahrens","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2026.06.004_bib158","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.actbio.2016.12.026","article-title":"Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices","volume":"50","author":"Sapudom","year":"2017","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib159","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-07-2140","article-title":"Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44","volume":"68","author":"Golshani","year":"2008","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.semcancer.2026.06.004_bib160","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1158\/0008-5472.CAN-04-0202","article-title":"Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44","volume":"64","author":"Kim","year":"2004","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib161","first-page":"2583","article-title":"Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas","volume":"62","author":"Yang","year":"2002","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib162","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.imbio.2011.12.006","article-title":"Increased hyaluronan levels and decreased dendritic cell activation are associated with tumor invasion in murine lymphoma cell lines","volume":"217","author":"Cordo Russo","year":"2012","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107944","article-title":"Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction","volume":"9","author":"Rizzo","year":"2014","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib164","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00262-011-1036-0","article-title":"Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma","volume":"60","author":"Alaniz","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2026.06.004_bib165","article-title":"Hyaluronan-Binding T Regulatory Cells in Peripheral Blood of Breast Cancer Patients","author":"Perfilyeva","year":"2015","journal-title":"J. Clin. & Cell. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib166","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2019.04.007","article-title":"Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma","volume":"71","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib167","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4161\/cib.3.6.13495","article-title":"Multifaceted regulation of T cells by CD44","volume":"3","author":"Baaten","year":"2010","journal-title":"Commun. & Integr. Biol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib168","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fimmu.2015.00068","article-title":"Interactions between CD44 and hyaluronan in leukocyte trafficking","volume":"6","author":"McDonald","year":"2015","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2026.06.004_bib169","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.4049\/jimmunol.0901683","article-title":"TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses","volume":"183","author":"Chandran","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib170","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1007\/s13346-023-01337-4","article-title":"Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma model","volume":"13","author":"Malfanti","year":"2023","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib171","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/IR:31:3:189","article-title":"Immunologic roles of hyaluronan","volume":"31","author":"Mummert","year":"2005","journal-title":"Immunol. Res."},{"key":"10.1016\/j.semcancer.2026.06.004_bib172","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fimmu.2015.00150","article-title":"The where, when, how, and why of hyaluronan binding by immune cells","volume":"6","author":"Lee-Sayer","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib173","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/bj2560153","article-title":"Uptake and degradation of hyaluronan in lymphatic tissue","volume":"256","author":"Fraser","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2026.06.004_bib174","first-page":"1","article-title":"Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review","author":"Salari","year":"2021","journal-title":"DARU J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.semcancer.2026.06.004_bib175","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.3390\/ijms242115812","article-title":"The Hyaluronan\/CD44 Axis: A Double-Edged Sword in Cancer","volume":"24","author":"Cirillo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib176","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/2326-6066.CIR-18-0500","article-title":"A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients","volume":"7","author":"Cursons","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib177","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1158\/1535-7163.MCT-14-0580","article-title":"Tumor-Associated Hyaluronan Limits Efficacy of Monoclonal Antibody Therapy","volume":"14","author":"Singha","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"6_ement","key":"10.1016\/j.semcancer.2026.06.004_bib178","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1158\/1538-7445.AM2024-2705","article-title":"Abstract 2705: Hyaluronic acid impairs NK killing towards breast tumor spheroids despite elevated cytotoxicity","volume":"84","author":"Cheung","year":"2024","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib179","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/path.2947","article-title":"Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4\/PI3K activation loop","volume":"225","author":"Wu","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.matbio.2016.07.011","article-title":"Fibronectin, the extracellular glue","volume":"60-61","author":"Zollinger","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib181","series-title":"Tumor Microenvironment: Extracellular Matrix Components \u2013 Part A","first-page":"85","article-title":"Fibronectin in the Tumor Microenvironment","author":"Qiao","year":"2020"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib182","first-page":"93","article-title":"High expression of fibronectin 1 indicates poor prognosis in gastric cancer","volume":"19","author":"Sun","year":"2020","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib183","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40164-023-00419-w","article-title":"Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK\/MAPK\/ HIF-1\u03b1 axis and activating wnt signaling pathway","volume":"12","author":"Zhou","year":"2023","journal-title":"Exp. Hematol. & Oncol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib184","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.2147\/OTT.S195703","article-title":"Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT","volume":"12","author":"Li","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib185","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neo.2021.06.012","article-title":"Inhibition of fibronectin accumulation suppresses tumor growth","volume":"23","author":"Ghura","year":"2021","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib186","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3835(83)90197-0","article-title":"Increased plasma fibronectin concentrations in tumor bearing mice","volume":"21","author":"Siri","year":"1983","journal-title":"Cancer Lett."},{"issue":"6892","key":"10.1016\/j.semcancer.2026.06.004_bib187","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib188","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.jid.5700524","article-title":"Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway","volume":"127","author":"Gaggioli","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib189","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bbrc.2005.06.039","article-title":"Interaction between integrin alpha(5) and fibronectin is required for metastasis of B16F10 melanoma cells","volume":"333","author":"Qian","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10555-005-1572-1","article-title":"Integrin signaling in malignant melanoma","volume":"24","author":"Kuphal","year":"2005","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib191","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1096\/fj.10-154435","article-title":"EDA-containing cellular fibronectin induces fibroblast differentiation through binding to \u03b14\u03b27 integrin receptor and MAPK\/Erk 1\/2-dependent signaling","volume":"24","author":"Kohan","year":"2010","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib192","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13046-018-0763-x","article-title":"Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma","volume":"37","author":"Huang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.semcancer.2026.06.004_bib193","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1182\/blood-2009-05-219881","article-title":"Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b\/Src\/\u03b2-catenin pathway","volume":"114","author":"Zhang","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib194","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.4049\/jimmunol.155.11.5314","article-title":"Cross-linking of alpha 4 beta 1 and alpha 5 beta 1 fibronectin receptors enhances natural killer cell cytotoxic activity","volume":"155","author":"Palmieri","year":"1995","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/intimm\/dxad012","article-title":"Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3\/LILRB4\/gp49B","volume":"35","author":"Itagaki","year":"2023","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib196","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4049\/jimmunol.165.5.2738","article-title":"TNF-\u03b1 associated with extracellular matrix fibronectin provides a stop signal for chemotactically migrating T cells","volume":"165","author":"Franitza","year":"2000","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.semcancer.2026.06.004_bib197","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1158\/0008-5472.CAN-14-2524","article-title":"Blocking Tumor Necrosis Factor \u03b1 Enhances CD8 T-cell\u2013dependent immunity in experimental melanoma","volume":"75","author":"Bertrand","year":"2015","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib198","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ijc.23553","article-title":"IFN-\u03b3 withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin \u03b1v\u03b23 signaling","volume":"123","author":"Gong","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"40","key":"10.1016\/j.semcancer.2026.06.004_bib199","doi-asserted-by":"crossref","first-page":"20141","DOI":"10.1073\/pnas.1901931116","article-title":"\u03b1v\u03b23-integrin regulates PD-L1 expression and is involved in cancer immune evasion","volume":"116","author":"Vannini","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib200","article-title":"Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade","volume":"6","author":"Khan","year":"2025","journal-title":"Cell. Rep. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib201","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00262-014-1562-7","article-title":"Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy","volume":"63","author":"Pretto","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcancer.2026.06.004_bib202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2015.11.014","article-title":"Fibronectin-targeted drug delivery in cancer","volume":"97","author":"Kumra","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib203","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00262-019-02383-z","article-title":"A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients","volume":"68","author":"Weide","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib204","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V99.5.1659","article-title":"Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix","volume":"99","author":"Carnemolla","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib205","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1878-0261.12705","article-title":"Human fibronectin extra domain B as a biomarker for targeted therapy in cancer","volume":"14","author":"Lieverse","year":"2020","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib206","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/2326-6066.CIR-13-0206","article-title":"Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19\u2013IL2 Results in Sustained Clinical and Systemic Immunologic Responses","volume":"2","author":"Weide","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib207","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/s41467-018-04525-w","article-title":"Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing","volume":"9","author":"Ishihara","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.06.004_bib208","series-title":"Engineering Neural Tissue from Stem Cells","first-page":"65","article-title":"Chapter 4 - Design considerations when engineering neural tissue from stem cells","author":"Willerth","year":"2017"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib209","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajpath.2013.09.020","article-title":"Melanoma spheroid formation involves laminin-associated vasculogenic mimicry","volume":"184","author":"Larson","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib210","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.yexcr.2010.12.019","article-title":"Melanoma cells produce multiple laminin isoforms and strongly migrate on \u03b15 laminin(s) via several integrin receptors","volume":"317","author":"Oikawa","year":"2011","journal-title":"Exp. Cell. Res."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib211","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063682","article-title":"LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis","volume":"12","author":"Fu","year":"2022","journal-title":"BMJ Open."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib212","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/TP.0000000000002774","article-title":"Differential Regulation of T-cell Immunity and Tolerance by Stromal Laminin Expressed in the Lymph Node","volume":"103","author":"Simon","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.semcancer.2026.06.004_bib213","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.cellbio.20.010403.094555","article-title":"Laminin functions in tissue morphogenesis","volume":"20","author":"Miner","year":"2004","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib214","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.matbio.2005.12.001","article-title":"Ligand-binding specificities of laminin-binding integrins: A comprehensive survey of laminin\u2013integrin interactions using recombinant \u03b13\u03b21, \u03b16\u03b21, \u03b17\u03b21 and \u03b16\u03b24 integrins","volume":"25","author":"Nishiuchi","year":"2006","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-6-17","article-title":"Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer","volume":"6","author":"Ulazzi","year":"2007","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.10.003","article-title":"Effect of laminin environments and tumor factors on the biology of myeloid dendritic cells","volume":"225","author":"Phillippi","year":"2020","journal-title":"Immunobiology"},{"issue":"34","key":"10.1016\/j.semcancer.2026.06.004_bib217","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1038\/s41388-021-01946-8","article-title":"DCision-making in tumors governs T cell anti-tumor immunity","volume":"40","author":"Alfei","year":"2021","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib218","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.immuni.2022.04.016","article-title":"Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing","volume":"55","author":"MacNabb","year":"2022","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib219","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc8346","article-title":"Laminin \u03b32\u2013mediating T cell exclusion attenuates response to anti\u2013PD-1 therapy","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcancer.2026.06.004_bib220","series-title":"Madame Curie Bioscience Database [Internet]","article-title":"Matrix metalloproteinases in cancer cell invasion","author":"Reunanen","year":"2013"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib221","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0092-8674(00)80429-8","article-title":"ECM and Cell Surface Proteolysis: Regulating Cellular Ecology","volume":"91","author":"Werb","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib222","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.00022.2006","article-title":"Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted","volume":"87","author":"Greenlee","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.semcancer.2026.06.004_bib223","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ijms17060868","article-title":"Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis","volume":"17","author":"Pittayapruek","year":"2016","journal-title":"Int. J. Mol. Sci. (IJMS)"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib224","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/ijtm4040046","article-title":"Shaping the Landscape of Lung Cancer: The Role and Therapeutic Potential of Matrix Metalloproteinases","volume":"4","author":"Ashja Ardalan","year":"2024","journal-title":"Int. J. Transl. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib225","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/biomedicines12081851","article-title":"Advances in Melanoma: From Genetic Insights to Therapeutic Innovations","volume":"12","author":"Valdez-Salazar","year":"2024","journal-title":"Biomedicines"},{"issue":"14","key":"10.1016\/j.semcancer.2026.06.004_bib226","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.3390\/ijms25147804","article-title":"Skin Malignant Melanoma and Matrix Metalloproteinases: Promising Links to Efficient Therapies","volume":"25","author":"Lazar","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib227","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051151","article-title":"Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma","volume":"9","author":"Napoli","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib228","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13073-020-00780-z","article-title":"Small-molecule MMP2\/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1","volume":"12","author":"Ye","year":"2020","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib229","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes. Dev."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib230","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.21037\/tcr-22-292","article-title":"Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-\u03b21 in epithelial-to-mesenchymal transition in melanoma","volume":"11","author":"Li","year":"2022","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib231","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2011.01.037","article-title":"Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory TH2 cells via an IL-12-and OX40L-dependent pathway","volume":"19","author":"Godefroy","year":"2011","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib232","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.celrep.2014.10.067","article-title":"Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses","volume":"9","author":"Godefroy","year":"2014","journal-title":"Cell. Rep."},{"key":"10.1016\/j.semcancer.2026.06.004_bib233","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2019.12.035","article-title":"Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice","volume":"318","author":"Hwang","year":"2020","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.semcancer.2026.06.004_bib234","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144913","article-title":"MMP2 and TLRs modulate immune responses in the tumor microenvironment","volume":"6","author":"Muniz-Bongers","year":"2021","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207255","article-title":"MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors","volume":"13","author":"Juric","year":"2018","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib236","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12967-014-0342-7","article-title":"Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy","volume":"12","author":"Moogk","year":"2014","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib237","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/cdd.2013.26","article-title":"Molecular mechanisms of natural killer cell activation in response to cellular stress","volume":"21","author":"Chan","year":"2014","journal-title":"Cell. Death & Differ."},{"issue":"12","key":"10.1016\/j.semcancer.2026.06.004_bib238","doi-asserted-by":"crossref","first-page":"19780","DOI":"10.18632\/oncotarget.15540","article-title":"Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion","volume":"8","author":"Ziani","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib239","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41435-024-00274-7","article-title":"TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity","volume":"25","author":"Langguth","year":"2024","journal-title":"Genes. & Immun."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. & Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib241","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jhep.2003.50191","article-title":"MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes","volume":"37","author":"Herkel","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib242","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Mari\u00f1o","year":"2023","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib243","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1755-148X.2012.01026.x","article-title":"The sweet and bitter sides of galectins in melanoma progression","volume":"25","author":"Braeuer","year":"2012","journal-title":"Pigment. Cell. & Melanoma Res."},{"issue":"22","key":"10.1016\/j.semcancer.2026.06.004_bib244","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1158\/1078-0432.CCR-06-0758","article-title":"Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma","volume":"12","author":"Prieto","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1_ement","key":"10.1016\/j.semcancer.2026.06.004_bib245","first-page":"B67","article-title":"Abstract B67: Galectin-1 expression related to hypoxia in primary human melanoma as a driver for metastatic progression. A target to promote anticancer immunotherapy","volume":"73","author":"Ralph","year":"2014","journal-title":"Cancer Res."},{"issue":"35","key":"10.1016\/j.semcancer.2026.06.004_bib246","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1200\/JCO.2005.02.0206","article-title":"Galectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege","volume":"23","author":"Le","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib247","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00262-021-03139-4","article-title":"Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden","volume":"71","author":"Femel","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib248","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.cellsig.2006.02.007","article-title":"Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1","volume":"18","author":"Ion","year":"2006","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.semcancer.2026.06.004_bib249","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/1878-0261.12695","article-title":"BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells","volume":"14","author":"G\u00f3rniak","year":"2020","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00262-017-1995-x","article-title":"IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma","volume":"66","author":"Melief","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib251","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41467-017-00925-6","article-title":"Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration","volume":"8","author":"Gordon-Alonso","year":"2017","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.semcancer.2026.06.004_bib252","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1158\/0008-5472.CAN-10-0761","article-title":"A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice","volume":"70","author":"Demotte","year":"2010","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.semcancer.2026.06.004_bib253","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1158\/0008-5472.CAN-08-1245","article-title":"Tumor-Associated Galectin-3 Modulates the Function of Tumor-Reactive T Cells","volume":"68","author":"Peng","year":"2008","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib254","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2353\/ajpath.2006.050971","article-title":"Galectin-3 Expression Correlates with Apoptosis of Tumor-Associated Lymphocytes in Human Melanoma Biopsies","volume":"168","author":"Zubieta","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib255","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis","volume":"127","author":"Seki","year":"2008","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.semcancer.2026.06.004_bib256","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib257","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1462061","article-title":"The regulating role of galectin-9 in immune cell populations","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib258","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/CMR.0000000000000281","article-title":"Galectin-9 modulates immunity by promoting Th2\/M2 differentiation and impacts survival in patients with metastatic melanoma","volume":"26","author":"Enninga","year":"2016","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib259","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"issue":"48","key":"10.1016\/j.semcancer.2026.06.004_bib260","doi-asserted-by":"crossref","first-page":"33311","DOI":"10.1074\/jbc.M114.603464","article-title":"Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.semcancer.2026.06.004_bib261","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/emboj.2011.215","article-title":"A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans","volume":"30","author":"Tsuboi","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2026.06.004_bib262","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1506236","article-title":"Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer - implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils","volume":"15","author":"Karlsson","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib263","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10585-011-9383-y","article-title":"Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity","volume":"28","author":"Radosavljevic","year":"2011","journal-title":"Clin. & Exp. Metastas-.-."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib264","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098116","article-title":"Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases","volume":"24","author":"Ahmed","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.semcancer.2026.06.004_bib265","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1158\/1078-0432.CCR-19-1259","article-title":"Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3K\u03b2 Inhibition in PTEN Loss Melanoma","volume":"25","author":"Peng","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib266","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1892265","article-title":"Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity","volume":"10","author":"Sturgill","year":"2021","journal-title":"OncoImmunology"},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib267","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002371","article-title":"Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor","volume":"9","author":"Curti","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib268","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-023-04513-y","article-title":"Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants","volume":"91","author":"Aslanis","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib269","first-page":"27","article-title":"Modeling Melanoma In Vitro and In Vivo","volume":"2","author":"Beaumont","year":"2013","journal-title":"Healthc. (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.3.1.1","article-title":"vitro three-dimensional tumor microenvironment models for anticancer drug discovery","volume":"3","author":"Smalley","year":"2008","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/j.semcancer.2026.06.004_bib271","series-title":"Cell Viability Assays: Methods and Protocols","first-page":"349","article-title":"Transwell In Vitro Cell Migration and Invasion Assays","author":"Justus","year":"2023"},{"key":"10.1016\/j.semcancer.2026.06.004_bib272","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.parkreldis.2008.04.003","article-title":"Thoughts on limitations of animal models","volume":"14","author":"Hartung","year":"2008","journal-title":"Park. & Relat. Disord."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib273","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040874","article-title":"Organoid and Spheroid Tumor Models: Techniques and Applications","volume":"13","author":"Gunti","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib274","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41416-023-02167-4","article-title":"Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges","volume":"128","author":"Basnayake","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104614","article-title":"Patient-derived melanoma organoid models facilitate the assessment of immunotherapies","volume":"92","author":"Ou","year":"2023","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib276","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00262-025-04269-9","article-title":"Modeling anti-tumor immune responses using patient-derived melanoma organoids","volume":"75","author":"Kaminska","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib277","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","article-title":"Tumor organoid\u2013T-cell coculture systems","volume":"15","author":"Cattaneo","year":"2020","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.semcancer.2026.06.004_bib278","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib279","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00262-024-03749-8","article-title":"Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures","volume":"73","author":"Li","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib280","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41587-022-01397-w","article-title":"Uncovering the mode of action of engineered T cells in patient cancer organoids","volume":"41","author":"Dekkers","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"47","key":"10.1016\/j.semcancer.2026.06.004_bib281","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr4831","article-title":"Acoustic virtual 3D scaffold for direct-interacting tumor organoid\u2013immune cell coculture systems","volume":"10","author":"Shan","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib282","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13287-022-02950-9","article-title":"Organoids: a systematic review of ethical issues","volume":"13","author":"de Jongh","year":"2022","journal-title":"Stem Cell. Res. & Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103090","article-title":"Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids","volume":"5","author":"Tan","year":"2024","journal-title":"STAR Protoc."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.104039","article-title":"Protocol for generation and utilization of patient-derived organoids from multimodal specimen","volume":"6","author":"Kang","year":"2025","journal-title":"STAR Protoc."},{"issue":"4","key":"10.1016\/j.semcancer.2026.06.004_bib285","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103353","article-title":"Protocol for culturing patient-derived organoids of cervical cancer","volume":"5","author":"Wang","year":"2024","journal-title":"STAR Protoc."},{"key":"10.1016\/j.semcancer.2026.06.004_bib286","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fdgth.2021.668390","article-title":"Fluorescence-Based Quantitative and Spatial Analysis of Tumour Spheroids: A Proposed Tool to Predict Patient-Specific Therapy Response","volume":"3","author":"Spoerri","year":"2021","journal-title":"Front. Digit. Health"},{"key":"10.1016\/j.semcancer.2026.06.004_bib287","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-1-4939-7021-6_29","article-title":"Real-Time Cell Cycle Imaging in a 3D Cell Culture Model of Melanoma","volume":"1612","author":"Spoerri","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib288","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73020","article-title":"Quantitative analysis of tumour spheroid structure","volume":"10","author":"Browning","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib289","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11538-023-01229-1","article-title":"Formation and Growth of Co-Culture Tumour Spheroids: New Compartment-Based Mathematical Models and Experiments","volume":"86","author":"Murphy","year":"2023","journal-title":"Bull. Math. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib290","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40425-019-0553-9","article-title":"Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA\/B and NKG2A targeting for cancer treatment","volume":"7","author":"Courau","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib291","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s42003-021-02296-7","article-title":"An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model","volume":"4","author":"Al-Hity","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib292","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fonc.2020.01543","article-title":"Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies","volume":"10","author":"Saraiva","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib293","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/acs.jproteome.2c00526","article-title":"Mass Spectrometry-Based Atlas of Extracellular Matrix Proteins across 25 Mouse Organs","volume":"22","author":"McCabe","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.semcancer.2026.06.004_bib294","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.596702","article-title":"Elastin Structure, Synthesis, Regulatory Mechanism and Relationship With Cardiovascular Diseases","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib295","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.17219\/acem\/104531","article-title":"Fibronectin and its soluble EDA-FN isoform as biomarkers for inflammation and sepsis","volume":"28","author":"Lema\u0144ska-Perek","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.semcancer.2026.06.004_bib296","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.matbio.2018.04.011","article-title":"Antibodies and methods for immunohistochemistry of extracellular matrix proteins","volume":"71-72","author":"Rickelt","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.semcancer.2026.06.004_bib297","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1191992","article-title":"Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations","volume":"14","author":"van der Pan","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib298","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cyto.a.24213","article-title":"OMIP-069: Forty-Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood","volume":"97","author":"Park","year":"2020","journal-title":"Cytom. Part. A"},{"key":"10.1016\/j.semcancer.2026.06.004_bib299","series-title":"Melanoma: Methods and Protocols","first-page":"515","article-title":"Immunotyping and Quantification of Melanoma Tumor\u2013Infiltrating Lymphocytes","author":"Meneveau","year":"2021"},{"issue":"186","key":"10.1016\/j.semcancer.2026.06.004_bib300","doi-asserted-by":"crossref","DOI":"10.3791\/64103","article-title":"Rapid Optical Clearing for Semi-High-Throughput Analysis of Tumor Spheroids","author":"Gunasingh","year":"2022","journal-title":"J. Vis. Exp."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib301","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41419-024-06598-6","article-title":"Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer","volume":"15","author":"Xiao","year":"2024","journal-title":"Cell. Death & Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib302","article-title":"Spatial transcriptomics-aided localization for single-cell transcriptomics with STALocator","volume":"16","author":"Li","year":"2025","journal-title":"Cell. Syst."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib303","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1038\/s41467-023-43629-w","article-title":"Integrating spatial and single-cell transcriptomics data using deep generative models with SpatialScope","volume":"14","author":"Wan","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.semcancer.2026.06.004_bib304","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1158\/0008-5472.CAN-23-1418","article-title":"Integration of Pan-Cancer Single-Cell and Spatial Transcriptomics Reveals Stromal Cell Features and Therapeutic Targets in Tumor Microenvironment","volume":"84","author":"Du","year":"2024","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2026.06.004_bib305","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","article-title":"Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics","volume":"22","author":"Longo","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib306","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41580-018-0094-y","article-title":"Spatial proteomics: a powerful discovery tool for cell biology","volume":"20","author":"Lundberg","year":"2019","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.06.004_bib307","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1038\/s41467-022-31659-9","article-title":"Spatially resolved proteomic map shows that extracellular matrix regulates epidermal growth","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib308","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1021\/acs.jproteome.4c00099","article-title":"The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma","volume":"23","author":"Macdonald","year":"2024","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.semcancer.2026.06.004_bib309","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26093949","article-title":"Spatial Omics in Clinical Research: A Comprehensive Review of Technologies and Guidelines for Applications","volume":"26","author":"Lee","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib310","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/exd.12400","article-title":"Melanoma never says die","volume":"23","author":"Haass","year":"2014","journal-title":"Exp. Dermatol."},{"issue":"11","key":"10.1016\/j.semcancer.2026.06.004_bib311","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167826","article-title":"Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment","volume":"134","author":"Fuller","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.semcancer.2026.06.004_bib312","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.semcancer.2026.06.004_bib313","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.semcancer.2026.06.004_bib314","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fonc.2021.764204","article-title":"3D Extracellular Matrix Regulates the Activity of T Cells and Cancer Associated Fibroblasts in Breast Cancer","volume":"11","author":"Gao","year":"2021","journal-title":"Front. Oncol."},{"issue":"22","key":"10.1016\/j.semcancer.2026.06.004_bib315","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review","volume":"332","author":"Brudno","year":"2024","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.semcancer.2026.06.004_bib316","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008659","article-title":"Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers","volume":"12","author":"Gargett","year":"2024","journal-title":"J. Immunother. Cancer"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2600060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X2600060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:24:59Z","timestamp":1788575099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X2600060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":316,"alternative-id":["S1044579X2600060X"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.06.004","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidden architecture of resistance: The extracellular matrix in melanoma\u2019s immune landscape","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}